Siddhartha Kadia

Siddhartha Kadia

Directeur Général chez MESA LABORATORIES, INC.

Fortune : 1 M $ au 31/08/2026

57 ans
Health Technology
Commercial Services
Consumer Services

Profil

Siddhartha C.
Kadia
is President, Chief Executive Officer & Director at Mesa Laboratories, Inc. since 2026.
Holds positions as Independent Non-Executive Director at ALS Ltd. since 2019, Director at BioSkryb, Inc. since 2020, Director at Applied Technical Services LLC since 2021, Director at SeQure DX, Inc., and Member-Overseers Board at The Scripps Research Institute.
Former roles include President, Chief Executive Officer & Director at Evans Analytical Group LLC; President, Chief Executive Officer & Director at Eurofins BioPharma Product Testing Columbia, Inc. from 2014 to 2018; President & Chief Executive Officer at Eurofins EAG Agroscience LLC from 2014 to 2018; Chief Executive Officer & Director at Bruker Cellular Analysis, Inc. from 2022 to 2023; Chief Executive Officer & Director at Phenomebio, Inc. from 2022 to 2023; Chief Executive Officer & Director at Calibre Scientific, Inc.; Independent Director at Newport Corp.
from 2014 to 2016; Independent Director at NuVasive LLC from 2021 to 2023; Independent Director at Philips Image Guided Therapy Corp.
from 2013 to 2015; Independent Director at IsoPlexis Corp.; Non-Executive Director at Horizon Discovery Group Ltd. in 2020; Independent Director at VIDA FLaSH Acquisitions; Director at Bioskryb Genomics, Inc.; Vice President-Global Marketing & eBusiness at Invitrogen Corp.
from 2005 to 2008; Neuroscientist at The Johns Hopkins University; President-Life Sciences Division at Life Technologies Corp.
from 2013 to 2014.
Education includes graduate studies at Rutgers State University of New Jersey, undergraduate studies at Gujarat University, and a doctorate from The Johns Hopkins University School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
13/08/2026 7 093 ( 0,13 % ) 906 982 $ 31/08/2026
31/03/2026 14 290 ( 0 % ) 227 656 $ 31/08/2026

Postes actifs de Siddhartha Kadia

SociétésPosteDébut
ALS LIMITED Directeur/Membre du Conseil 15/01/2019
MESA LABORATORIES, INC. Directeur Général 12/04/2026
Directeur/Membre du Conseil -
Corporate Officer/Principal -
Directeur/Membre du Conseil 01/04/2021
Directeur/Membre du Conseil 09/01/2020

Anciens postes connus de Siddhartha Kadia

SociétésPosteFin
BRUKER CELLULAR ANALYSIS, INC. Directeur Général 01/09/2023
NUVASIVE, INC. Directeur/Membre du Conseil 01/09/2023
Directeur Général 01/08/2023
░░░░░░░ ░░░░░░░░░ ░░░░░ ░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Siddhartha Kadia

Formation de Siddhartha Kadia

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

61

Relations au 1er degré

25

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées25

Electronic Technology

Health Technology

Electronic Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Commercial Services

Commercial Services

Consumer Services

Distribution Services

Technology Services

Distribution Services

Health Services

Commercial Services

Finance

Health Services

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Siddhartha Kadia
-40% : Prolongation exceptionnelle ➤➤➤➤
j
:
:
PROFITEZ-EN MAINTENANT
🔇